Purchases and Sales Made in Q2 2025 in Design Therapeutics, Inc. (DSGN)
This table provides information about the institutional ownership of Design Therapeutics, Inc. (DSGN) during Q2 2025. The information is specifically focused on institutions that hold shares of Design Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2025
Q2 2025
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-3.98K- 22.77% |
$11.1K - $19.3K
|
13.5K
$67.2K
|
|
|
Aug 14, 2025
Q2 2025
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-4.6K- 1.16% |
$12.8K - $22.4K
|
391K
$1.95M
|
|
|
Aug 14, 2025
Q2 2025
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-5.05K- 11.69% |
$14.1K - $24.6K
|
38.2K
$190K
|
|
|
Aug 14, 2025
Q2 2025
|
Ubs Group Ag
|
SELL
|
- |
-5.48K- 16.69% |
$15.3K - $26.6K
|
27.3K
$136K
|
|
|
Jul 11, 2025
Q2 2025
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-5.79K- 15.69% |
$16.2K - $28.1K
|
31.1K
$155K
|
|
|
Aug 12, 2025
Q2 2025
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-7.43K- 2.87% |
$20.7K - $36.1K
|
251K
$1.25M
|
|
|
Aug 15, 2025
Q2 2025
|
Caz Investments LP
Houston, TX |
SELL
|
- |
-7.5K- 50.0% |
$20.9K - $36.5K
|
7.5K
$37.4K
|
|
|
Aug 08, 2025
Q2 2025
|
Pnc Financial Services Group, Inc.
Pittsburgh, PA |
SELL
|
- |
-7.58K- 81.94% |
$21.1K - $36.8K
|
1.67K
$8.32K
|
|
|
Aug 14, 2025
Q2 2025
|
Bio Impact Capital LLC
Cambridge, MA |
SELL
|
- |
-7.76K- 1.38% |
$21.6K - $37.7K
|
555K
$2.76M
|
|
|
Aug 11, 2025
Q2 2025
|
Citigroup Inc
|
SELL
|
- |
-9.23K- 40.35% |
$25.8K - $44.9K
|
13.6K
$68K
|
|
|
Aug 14, 2025
Q2 2025
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-10.6K- 0.59% |
$29.7K - $51.7K
|
1.81M
$9M
|
|
|
Aug 13, 2025
Q2 2025
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-11.1K- 2.98% |
$31.1K - $54.1K
|
363K
$1.81M
|
|
|
Jul 22, 2025
Q2 2025
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-12.2K- 16.87% |
$34K - $59.2K
|
60K
$299K
|
|
|
Aug 12, 2025
Q2 2025
|
Nuveen, LLC
Charlotte, NC |
SELL
|
- |
-14.2K- 9.64% |
$39.6K - $69K
|
133K
$662K
|
|
|
Aug 14, 2025
Q2 2025
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-26.6K- 9.98% |
$74.1K - $129K
|
239K
$1.19M
|
|
|
Aug 14, 2025
Q2 2025
|
Baker Bros. Advisors LP
New York, NY |
SELL
|
- |
-30.8K- 1.77% |
$86.1K - $150K
|
1.71M
$8.53M
|
|
|
Aug 15, 2025
Q2 2025
|
Morgan Stanley
New York, NY |
SELL
|
- |
-34.3K- 13.85% |
$95.8K - $167K
|
214K
$1.06M
|
|
|
Aug 14, 2025
Q2 2025
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-38.2K- 26.04% |
$107K - $186K
|
109K
$540K
|
|
|
Aug 14, 2025
Q2 2025
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-39.4K- 30.63% |
$110K - $192K
|
89.3K
$445K
|
|
|
Aug 14, 2025
Q2 2025
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-123K- 12.73% |
$342K - $596K
|
841K
$4.19M
|